Key result
Random upright urine samples detect microalbuminuria with ~89% sensitivity, outperforming first morning voids.
Why the study?
Microalbuminuria in patients with type I diabetes predicts diabetic renal disease, but the effectiveness of single-sample urine collections for screening is unclear.
Do single-sample urine collections accurately detect microalbuminuria compared to 24-hour urine collections in patients with type I diabetes?
Cross-Sectional (n=94)
Do single-sample urine collections accurately detect microalbuminuria compared to 24-hour urine collections in patients with type I diabetes?
Absolute Event Rate: 89% vs 70%
Random upright single-sample urine collections provide a sensitive and specific method for screening microalbuminuria in patients with type I diabetes, offering immediate results when reagent tablets are used.
Random upright samples may aid microalbuminuria screening in type 1 diabetes; leaves open prospective validation against 24-hour collections.
OBJECTIVE: To evaluate single-sample urine collections to determine their ability to screen patients for the presence of microalbuminuria. Microalbuminuria in patients with type I diabetes predicts the development of diabetic renal disease. RESEARCH DESIGN AND METHODS: Cross-sectional analysis of single-sample urine collection techniques (first morning void, random upright void) and methods of albumin analysis (RIA, reagent tablet) were compared with conventional 24-h urine collections (RIA). The study included 94 patients (45 males, 49 females; mean serum creatinine 88 microM) with type I diabetes, selected from a screened population of 301 patients from the University Hospital Subspecialty Clinics. RESULTS: A 24-hour urine collection RIA analysis for albumin revealed 36 normal patients (< 30 mg), 27 with microalbuminuria (30-300 mg), and 31 with albuminuria (> 300 mg). Random upright urine samples were more sensitive (RIA 89%, tablets 78%) for the detection of microalbuminuria than first morning void specimens (RIA 70%, tablets 60%). Specificity was > 80% with both random and first morning voids. CONCLUSIONS: Screening for microalbuminuria can be performed in the clinic by random upright single-sample urine collections. When reagent tablets were used, these results are available immediately. Patients who screen positive should be confirmed by 24-h or other timed urine collections.
No takes yet. Share an insight, caveat, or question.
Schwab et al. (1992) conducted a cross-sectional in Type I diabetes (n=94). Random upright single-sample urine collections vs. First morning void specimens and 24-h urine collections was evaluated on Sensitivity for the detection of microalbuminuria. Random upright urine samples were more sensitive (RIA 89%, tablets 78%) than first morning void specimens (RIA 70%, tablets 60%) for detecting microalbuminuria.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: